Cargando…
Lewy body disease as a potential negative outcome modifier of glioblastoma treatment: a case report
BACKGROUND: Elderly patients with glioblastoma are particularly susceptible to the adverse effects of ionizing radiation to the brain. This population also has an increasing prevalence of dementia in the successive seventh, eighth and nineth decade of life, and dementia with Lewy bodies is character...
Autores principales: | Wong, Eric T., Rosenberg, Harry, Dawood, Olivia, Hertan, Lauren, Vega, Rafael A., Anderson, Matthew, Uhlmann, Erik J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318781/ https://www.ncbi.nlm.nih.gov/pubmed/37403078 http://dx.doi.org/10.1186/s12883-023-03313-4 |
Ejemplares similares
-
Rapid Progressive Glioblastoma despite Radiation in a Patient with Myelodysplastic Syndrome
por: Wong, Eric T., et al.
Publicado: (2021) -
Leukopenia is a biomarker for effective temozolomide dosing and predicts overall survival of patients with glioblastoma
por: Ho, K. Grace, et al.
Publicado: (2020) -
Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies
por: Koss, David J., et al.
Publicado: (2022) -
Lewy body disease and dementia with Lewy bodies
por: KOSAKA, Kenji
Publicado: (2014) -
Lewy body disease or diseases with Lewy bodies?
por: Menšíková, Kateřina, et al.
Publicado: (2022)